Y-Intercept (Hong Kong) Ltd

Position in GSK — GSK plc

CIK 1772875 HONG KONG, K3

Position in GSK

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$1,273,229

-$1,440,132 QoQ

Shares Held

24,289

-50.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#317

of 1,033 holders

Holding Since

Jun 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Y-Intercept (Hong Kong) Ltd holds $55,696,959 across 11 Drug Manufacturers - General names. GSK ranks #8 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	74,248	$18,683,766
2	LLY	ELI LILLY & Co	8,310	$9,967,264
3	GILD	Gilead Sciences, Inc.	57,007	$7,202,264
4	MRK	Merck & Co., Inc.	51,433	$6,609,140
5	NVO	Novo Nordisk A S	86,018	$4,123,702
6	BMY	Bristol Myers Squibb Co	46,615	$2,685,956
7	AMGN	Amgen Inc	5,281	$1,912,355
8	GSK	GSK plc This page	24,289	$1,273,229

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,273,229	24,289	-50.6%	Shares	Sole	2026-07-14
2026-03-31	$2,713,361	49,164	+779.7%	Shares	Sole	2026-04-27
2025-09-30	$241,221	5,589	-75.5%	Shares	Sole	2025-10-31
2025-06-30	$877,017	22,839	-57.0%	Shares	Sole	2025-08-01
2024-09-30	$2,169,828	53,078	-23.1%	Shares	Sole	2024-11-15
2024-06-30	$2,658,617	69,055	+57.3%	Shares	Sole	2024-08-14
2023-12-31	$1,626,489	43,888	-41.4%	Shares	Sole	2024-02-13
2023-09-30	$2,716,067	74,926	+158.5%	Shares	Sole	2023-11-14
2023-06-30	$1,032,954	28,983	-67.4%	Shares	Sole	2023-08-14
2023-03-31	$3,166,264	88,990	+143.6%	Shares	Sole	2023-05-09
2022-12-31	$1,283,804	36,534	-56.8%	Shares	Sole	2023-02-14
2022-09-30	$2,489,925	84,605	+206.1%	Shares	Sole	2023-02-14
2021-12-31	$1,195,390	27,637	+30.0%	Shares	Sole	2022-02-14
2021-06-30	$830,240	21,258	—	Shares	Sole	2021-08-26
No filing history on record for this holder in this stock.